Anzeige
Mehr »
Mittwoch, 19.08.2026 - Börsentäglich über 12.000 News
NurExone Biologic! Massiver Turnaround - jetzt die Rallye?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrSYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?
Fr4 Stocks With More Than 35% Upside to Buy After Q2 Earnings
FrThe AI Stock Everyone Knows - But Few See Becoming a Future Winner
FrLamar Acquires AdSource Outdoor Assets Through UPREIT Transaction
FrPayPal Cost Savings: Will $1.5B Plan Reshape Profitability?
FrCan AWR Continue Raising Dividends for Long-Term Shareholders?
FrEverest Group Lags Industry, Trades at a Discount: Time to Hold?
FrWTW Stock Surges 34.5% in Three Months: What Should Investors Do Now?
FrAmerican Airlines Advances Sustainable Aviation Fuel Adoption
FrCan ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026?
FrBerkshire Hathaway vs. Progressive: Which Insurance Powerhouse Leads?
FrShould You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk?
FrSFM Q2 Results Show Store Growth Strength but Margin Pressure Builds
FrANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth
FrIs SFM Stock a Buy Now as Valuation Meets Slower Comparable Sales?
FrSFM Jumps 12.2% in a Month as Growth Drivers Face a Tough Margin Test
FrIs Costco Stock Worth Buying Now or Still Too Pricey to Touch?
FrCapri Holdings Advances Brand Revitalization & Operational Efficiency
FrCapri Holdings Cuts 2027 Sales View Despite Stronger Profitability
FrShould You Buy Capri Holdings as Value Clashes With Turnaround Risk?
FrCan Rithm Sustain Its 9.6% Yield as Costs and Liquidity Risks Rise?
FrAIT Q4 Earnings Beat Estimates on Strong Organic Sales Growth
FrEAT's Fiscal 2027 Guidance Gets a Boost From the 53rd Operating Week
FrIs Rithm Worth Buying as Low Valuation Meets Rising Cost Pressures?
FrAltria Rises 13% YTD: Should You Buy, Sell or Hold the Stock?